2
|
Zengel B, Yararbas U, Sirinocak A, Ozkok G, Denecli AG, Postaci H, Uslu A. Sentinel Lymph Node Biopsy in Breast Cancer: Review on Various Methodological Approaches. TUMORI JOURNAL 2018; 99:149-53. [DOI: 10.1177/030089161309900205] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aims and background Sentinel lymph node biopsy has been accepted as a standard procedure for early stage breast cancer. In this retrospective analysis, the results obtained with different methodological approaches using radiocolloid with or without blue dye were examined. Methods A total of 158 sentinel lymph node biopsies were performed in 152 patients. Group A (85 patients) underwent lymphatic mapping using a combination of periareolar intradermal radiocolloid and subareolar blue dye injections. Group B (73 patients) underwent only periareolar intradermal radiocolloid injection. One large tin colloid and two small radiocolloids (nanocolloid of serum albumin -NC- and colloidal rhenium sulphide -CS-) were used. Results Successful lymphatic mapping was attained in 157 of 158 procedures (99.4%). Radiocolloids localized sentinel lymph nodes in 99.4% and blue dye in 75.3% of the cases. The number of sentinel lymph nodes removed was greater in nanocolloid and colloidal rhenium sulphide groups ( P ≤0.05). Among 60 metastatic sentinel lymph nodes, frozen section analysis using hematoxylin and eosin staining failed to detect 1 macro- and 10 micrometastasis. Radiocolloid uptake was higher in sentinel lymph nodes accumulating blue dye (1643 ± 3216 counts/10 sec vs 526 ± 1284 counts/10 sec, P <0.001). Higher count rates were obtained by using larger sized colloids (median and interquartile range: tin colloid, 2050 and 4548; nanocolloid, 835 and 1799; colloidal rhenium sulphide, 996 and 2079; P = 0.01). Only 2 extra-axillary sentinel lymph nodes were visualized using periareolar intradermal injection modality. Conclusions Radiocolloids were more successful than blue dye in sentinel lymph node detection. More sentinel lymph nodes were harvested with small colloids, but different sized radiocolloids were similarly successful. Sentinel lymph nodes having higher radiocolloid uptake tended to accumulate blue dye more frequently. Sentinel lymph nodes manifested higher count rates when a larger colloid was used. Frozen section was very successful in detecting macrometastatic disease in sentinel lymph nodes, but the technique failed in most of the micrometastates.
Collapse
Affiliation(s)
- Baha Zengel
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of General Surgery, Izmir, Turkey
| | - Ulkem Yararbas
- Ege University, Medical Faculty, Department of Nuclear Medicine, Bornova, Izmir, Turkey
| | - Ahmet Sirinocak
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of General Surgery, Izmir, Turkey
| | - Guliz Ozkok
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of Pathology, Izmir, Turkey
| | - Ali Galip Denecli
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of General Surgery, Izmir, Turkey
| | - Hakan Postaci
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of Pathology, Izmir, Turkey
| | - Adam Uslu
- Turkish Ministry of Health Izmir Bozyaka Research and Training Hospital, Department of General Surgery, Izmir, Turkey
| |
Collapse
|
3
|
Gelsomino F, Castellani MR, Marchianò A, Duca M, Mariani P, Aliberti G, Maccauro M, Duranti L, Capri G, de Braud FG, Bianchi GV. Pitfalls in oncology: a unique case of thoracic splenosis mimicking malignancy in a patient with resected breast cancer. J Thorac Dis 2016; 8:E403-7. [PMID: 27293867 DOI: 10.21037/jtd.2016.04.54] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Thoracic splenosis (TS) is a condition of autotransplantation of splenic tissue into the pleural cavity after thoraco-abdominal trauma, with diaphragmatic and spleen injury. It is usually asymptomatic and discovered as an incidental finding at imaging performed for other reasons. Its differential diagnosis regards different benign and malignant conditions and should be discerned avoiding invasive procedures. We report a case of thoracic mass associated with pleural nodules mimicking malignancy in a patient with resected breast cancer for whom a diagnosis of TS was made early by using non-invasive methods. Briefly, we review the literature data on TS, comment concisely the possible implications of using invasive procedures and describe the current non-invasive techniques available. Furthermore, we highlight the importance of an accurate medical history collection, the role of the multidisciplinary board and their impact on treatment decision making. Finally, we conclude that clinical information and imaging would be the discriminating factors to avoid unnecessary invasive procedures.
Collapse
Affiliation(s)
- Francesco Gelsomino
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Maria Rita Castellani
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Alfonso Marchianò
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Matteo Duca
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Paola Mariani
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Gianluca Aliberti
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Marco Maccauro
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Leonardo Duranti
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Giuseppe Capri
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Filippo Guglielmo de Braud
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Giulia Valeria Bianchi
- 1 Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 2 Nuclear Medicina Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 3 Radiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy ; 4 Thoracic Surgery Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| |
Collapse
|